510(k) Report

510(k) · Cleared

Recalled · 2010

Cholesterol Asssay Kit

K842160510(k) TraditionalCleared Aug 17, 198479-day reviewClass I21 CFR 862.1175Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Chemicals, Ltd. (Usa) · CHH Enzymatic Esterase--Oxidase, Cholesterol

Cleared on Aug 17, 1984 after a 79-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Aug 17, 1984
Review
79 days
Class
Class I
Product code
CHH
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K842160Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CHH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CHH device

  1. #1 K251091 Lipidsscore 10.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 10, 2010Not classifiedZ-0711-2011Labeling mix-upsCholesterol Reagent bottles labels reversed for R1 and R2

No ancestor or descendant has a Class I recall.

How does its category compare?

All CHH devices

CHH Enzymatic Esterase--Oxidase, Cholesterol: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CHH

1in 2025

2007: 22008: 22009: 12011: 12012: 42013: 12014: 12015: 12016: 12017: 12018: 22019: 12022: 12024: 12025: 1
2007high 4 (2012) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CHH

198in 2012

2012: 198 days median
2007high 198 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CHH

2in 2021

2009: 32010: 22013: 12014: 12016: 22021: 22026 (partial year): 1
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CHH

14in 2025

2007: 12010: 102011: 182012: 112014: 12016: 52017: 22018: 12019: 52020: 12021: 22022: 42023: 42024: 82025: 14
2007high 18 (2011) · low 0 (2008)2025

MAUDE reports naming product code CHH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—00
20091—30
20100—210
20111—018
20124198011
20131—10
20141—11
20151—00
20161—25
20171—02
20182—01
20191—05
20200—01
20210—22
20221—04
20230—04
20241—08
20251—014
20260—1—
Cite this page

510(k) Report. “K842160: Cholesterol Asssay Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K842160

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026